Intellectual Property India Publishes Patent Application for 'Sustained-Release Microspheres Including Glp-1 Receptor Agonist Or Pharmaceutically Acceptable Salt Thereof And Use Thereof' Filed by Peptron, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202537057238 A) filed by Peptron, Inc., Daejeon, Republic of Korea, on June 14, for 'sustained-release microspheres including glp-1 receptor agonist or pharmaceutically acceptable salt thereof and use thereof.'

Inventor(s) include Chang, Seung Gu; Cho, Jae Pyoung; Lee, Ji Hyang; Jang, Eun Seo; Bae, Ji Hyun; and Choi, Ho Il.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a sustained-release microsphere containing a GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof and a sustained-release formulation. More specifically, the present invention relates to a sustained release formulation comprising a GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof, wherein the formulation includes sustained release microsphere containing the GLP-1 receptor agonist or a pharmaceutically acceptable salt thereof, one type of low-viscosity PLGA with an intrinsic viscosity of 0.14 to 0.24 dL/g, and two or more types of high-viscosity PLGA with an intrinsic viscosity of 0.32 to 0.60 dL/g and is free of problems associated with initial burst release and delayed release, thus enabling prolonged drug release and excellent bioavailability."

The patent application was internationally filed on Dec. 18, 2023, under International application No.PCT/KR2023/020910.

Disclaimer: Curated by HT Syndication.